Diaceutics (LON:DXRX) Hits New 1-Year High – What’s Next?

Shares of Diaceutics PLC (LON:DXRX) hit a new 52-week high on Thursday . The company traded as high as GBX 180 and last traded at GBX 180, with a volume of 246222 shares. The stock had previously closed at GBX 174.

Wall Street Analysts Forecast Growth

Separately, Shore Capital Group boosted their price target on Diaceutics from GBX 180 to GBX 215 and gave the stock a “buy” rating in a research note on Thursday, January 15th. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of GBX 193.33.

Diaceutics Trading Up 3.4%

The stock has a 50-day moving average of GBX 155.28 and a 200 day moving average of GBX 153.75. The stock has a market cap of £152.33 million, a PE ratio of -100.00 and a beta of 0.94. The company has a quick ratio of 9.92, a current ratio of 3.96 and a debt-to-equity ratio of 3.05.

About Diaceutics

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.